A brief review of cardiovascular diseases, associated risk factors and current treatment regimes

GD Flora, MK Nayak - Current pharmaceutical design, 2019 - ingentaconnect.com
Cardiovascular diseases (CVDs) are the leading cause of premature death and disability in
humans and their incidence is on the rise globally. Given their substantial contribution …

Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association

BW McCrindle, AH Rowley, JW Newburger, JC Burns… - circulation, 2017 - Am Heart Assoc
Background: Kawasaki disease is an acute vasculitis of childhood that leads to coronary
artery aneurysms in≈ 25% of untreated cases. It has been reported worldwide and is the …

[HTML][HTML] Timing of complete revascularization with multivessel PCI for myocardial infarction

BE Stähli, F Varbella, A Linke, B Schwarz… - … England Journal of …, 2023 - Mass Medical Soc
Background In patients with ST-segment elevation myocardial infarction (STEMI) with
multivessel coronary artery disease, the time at which complete revascularization of …

Part 3: adult basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care

AR Panchal, JA Bartos, JG Cabañas, MW Donnino… - Circulation, 2020 - Am Heart Assoc
These guidelines contain recommendations for basic life support (BLS) and advanced life
support (ALS) for adult patients and are based on the best available resuscitation science …

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of …

B Ibanez, S James, S Agewall, MJ Antunes… - European heart …, 2018 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy …

M Valgimigli, H Bueno, RA Byrne, JP Collet… - European heart …, 2018 - academic.oup.com
Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …

International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management

JR Ghadri, IS Wittstein, A Prasad… - European Heart …, 2018 - academic.oup.com
The clinical expert consensus statement on takotsubo syndrome (TTS) part II focuses on the
diagnostic workup, outcome, and management. The recommendations are based on …

2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College …

SM Al-Khatib, WG Stevenson, MJ Ackerman… - Journal of the American …, 2018 - jacc.org
The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

[PDF][PDF] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

P Ponikowski, AA Voors, SD Anker… - Kardiologia Polska …, 2016 - journals.viamedica.pl
5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of …

GN Levine, ER Bates, JA Bittl, RG Brindis, SD Fihn… - Circulation, 2016 - Am Heart Assoc
The scope of this focused update is limited to addressing recommendations on duration of
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …